Valeant Providing Reporters With an Earnings Metric the SEC Ordered it to Stop Using Post author:Sam Post published:November 9, 2017 Post category:BioPharma Valeant is not the only company to recently push reporters to defy the SEC’s orders. Source: BioSpace You Might Also Like BC Platforms Closes USD $10 Million Series B Financing Led By Debiopharm And To Accelerate Knowledge Platform Development May 8, 2017 Zomedica Announces First Quarter 2017 Financial Results May 11, 2017 TapImmune Brings on Former Bellicum Exec as New CEO September 24, 2017
BC Platforms Closes USD $10 Million Series B Financing Led By Debiopharm And To Accelerate Knowledge Platform Development May 8, 2017
